CompletedNot Applicable

Pharmacokinetic of Posaconazole in Critically Ill Patients

Germany10 participantsStarted 2021-02-11

Plain-language summary

The posaconazole pharmacokinetic in critically ill patients will be studied in a prospective, non-interventional, monocentric observational trial.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * treatment with intravenous posaconazole * critically ill patient * written declaration of consent Exclusion Criteria: \- no declaration of consent

What they're measuring

Posaconazole Drug Exposure

Timeframe: seven days from therapystart

Trial details

NCT IDNCT05275179

SponsorUniversitätsklinikum Hamburg-Eppendorf

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-03-30

View on ClinicalTrials.gov More Therapeutic Drug Monitoring trials